Mineralys Therapeutics, Inc. (MLYS)

CIK 1933414 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Mineralys Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 9, 20261440001964306-26-000434
Aug 25, 202640001916048-26-000012
Aug 21, 20261440001964306-26-000406
Aug 17, 20261440001964306-26-000390
Aug 13, 20261440001964306-26-000385
Aug 12, 202630001933414-26-000119
Aug 12, 202640001933414-26-000120
Aug 12, 202640001933414-26-000118
Aug 11, 20268-K0001933414-26-000112
Aug 11, 202610-Q0001933414-26-000114
Aug 10, 20261440001964306-26-000377
Aug 6, 2026SCHEDULE 13G/A0000315066-26-002085
Jul 23, 202640001916048-26-000009
Jul 21, 20261440001964306-26-000324
Jul 20, 202640001672659-26-000036
Jul 17, 20261440001964306-26-000322
Jul 15, 202640001933414-26-000099
Jul 15, 20261440001964306-26-000318
Jul 15, 202640001933414-26-000100
Jul 14, 2026144/A0001964306-26-000317
Jul 13, 20261440001964306-26-000315
Jul 13, 20261440001964306-26-000316
Jul 10, 202640001672659-26-000033
Jul 9, 20261440001964306-26-000312
Jun 30, 202640001933414-26-000095